Specialty Pharma Journal Specialty, Precision & Technology
PHILADELPHIA – A targeted therapy that has shown its power in fighting ovarian cancer in women including those with BRCA1 and BRCA2 mutations may also help patients with aggressive pancreatic cancer who harbor these mutations and have few or no other treatment options. An international team of researchers led by the Perelman School of Medicine and the Basser Center …
Tag Archives: University of Pennsylvania
May, 2018
June, 2017
-
14 June
Study Sheds New Light on Inherited Testicular Cancer Risk
PHILADELPHIA – An analysis of data from five major studies of testicular cancer has identified new genetic locations that could be susceptible to inherited testicular germ cell tumors. The findings, which researchers call a success story for genome mapping, could help doctors understand which men are at the highest risk …
March, 2017
-
17 March
Prevention and Prediction: Understanding how Lung Cancer Progresses
PHILADELPHIA – Treating the brain with a preventative course of radiation may help Small Cell Lung Cancer (SCLC) patients – whose tumors often spread to their brain — live longer, according to a new study from researchers in the Abramson Cancer Center and Perelman School of Medicine at the University …
February, 2017
-
24 February
Incyte Enters Immunotherapy Research Alliance with University of Pennsylvania’s Cancer Center
WILMINGTON, Del.–(BUSINESS WIRE)–Incyte Corporation (Nasdaq:INCY) today announces a multi-year research collaboration with the Abramson Cancer Center at the University of Pennsylvania. Through this collaboration, Incyte and Abramson have agreed to bring together the knowledge and expertise of their leading drug discovery and development scientists to conduct collaborative research aimed at …
September, 2016
-
12 September
Case for Liquid Biopsies Builds in Advanced Lung Cancer
PHILADELPHA— For patients with advanced lung cancer, a non-invasive liquid biopsy may be a more effective and suitable alternative to the gold standard tissue biopsy to detect clinically relevant mutations and help guide their course of treatment, suggests a new study published this week in the journal Clinical Cancer Research …
May, 2016
-
16 May
Biogen Collaborates with University of Pennsylvania to Advance Gene Therapy and Gene Editing Technologies
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Biogen (NASDAQ:BIIB) today announced a broad collaboration and alliance with the University of Pennsylvania (“Penn”) to advance gene therapy and gene editing technologies. The expansive research and translational development collaboration has multiple objectives, but will primarily focus on the development of therapeutic approaches that target the eye, skeletal muscle and the central nervous system …
-
9 May
Changes Needed to Increase Access to Colorectal Cancer Screening
PHILADELPHIA –– Colorectal cancer is the second highest cause of cancer death in the United States, expected to claim the lives of an estimated 49,190 people in 2016. The Affordable Care Act (ACA) aimed to increase access to CRC screening by not holding patients responsible for all costs of the …
April, 2016
-
29 April
Making Precision Medicine A Reality: Genomics Researchers Unveil Road Map to Disease Origin
TUCSON, Ariz. – Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies – thanks to work by three computational biology research teams from the University of Arizona Health Sciences, University …
January, 2016
-
4 January
Experts Find Breast Cancer Drug May be Effective in Other Cancer Types
PHILADELPHIA—Palbociclib, a new oral drug whose efficacy in combating breast cancer has been demonstrated alone and in combination with endocrine therapy, also has potential to combat other types of cancer, according to a literature review and additional original research conducted by experts at the Abramson Cancer Center (ACC) in the University …